These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Regulation of the Balb/c-3T3 cell cycle-effects of growth factors. Stiles CD; Pledger WJ; Tucker RW; Martin RG; Scher CD J Supramol Struct; 1980; 13(4):489-99. PubMed ID: 6453256 [TBL] [Abstract][Full Text] [Related]
5. Control of the Balb/c-3T3 cell cycle by nutrients and serum factors: analysis using platelet-derived growth factor and platelet-poor plasma. Stiles CD; Isberg RR; Pledger WJ; Antoniades HN; Scher CD J Cell Physiol; 1979 Jun; 99(3):395-405. PubMed ID: 222785 [TBL] [Abstract][Full Text] [Related]
6. Interferon inhibits the establishment of competence in Go/S-phase transition. Lin SL; Kikuchi T; Pledger WJ; Tamm I Science; 1986 Jul; 233(4761):356-9. PubMed ID: 3726533 [TBL] [Abstract][Full Text] [Related]
7. Effect of ouabain on growth regulation by serum components in Balb/c-3T3 cells: inhibition of entry into S phase by decreased protein synthesis. Frantz CN; Stiles CD; Pledger WJ; Scher CD J Cell Physiol; 1980 Dec; 105(3):439-48. PubMed ID: 6257737 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of BALB/c-3T3 cells in late G1: commitment to DNA synthesis controlled by somatomedin C. Wharton W; Van Wyk JJ; Pledger WJ J Cell Physiol; 1981 Apr; 107(1):31-9. PubMed ID: 7194350 [TBL] [Abstract][Full Text] [Related]
10. Platelet-derived growth factor-induced alterations in vinculin and actin distribution in BALB/c-3T3 cells. Herman B; Pledger WJ J Cell Biol; 1985 Apr; 100(4):1031-40. PubMed ID: 3920222 [TBL] [Abstract][Full Text] [Related]
11. Induction of DNA synthesis in BALB/c 3T3 cells by serum components: reevaluation of the commitment process. Pledger WJ; Stiles CD; Antoniades HN; Scher CD Proc Natl Acad Sci U S A; 1977 Oct; 74(10):4481-5. PubMed ID: 270695 [TBL] [Abstract][Full Text] [Related]
12. Platelet-derived growth factor-modulated proteins: constitutive synthesis by a transformed cell line. Pledger WJ; Hart CA; Locatell KL; Scher CD Proc Natl Acad Sci U S A; 1981 Jul; 78(7):4358-62. PubMed ID: 6170062 [TBL] [Abstract][Full Text] [Related]
13. Growth factor regulation of cyclin D1 mRNA expression through protein synthesis-dependent and -independent mechanisms. Winston JT; Pledger WJ Mol Biol Cell; 1993 Nov; 4(11):1133-44. PubMed ID: 8305735 [TBL] [Abstract][Full Text] [Related]
14. Epidermal growth factor (EGF) is required only during the traverse of early G1 in PDGF stimulated density-arrested BALB/c-3T3 cells. Leof EB; Van Wyk JJ; O'Keefe EJ; Pledger WJ Exp Cell Res; 1983 Aug; 147(1):202-8. PubMed ID: 6604639 [TBL] [Abstract][Full Text] [Related]
15. Modulation of the epidermal growth factor receptor by platelet-derived growth factor and choleragen: effects on mitogenesis. Wharton W; Leof E; Pledger WJ; O'Keefe EJ Proc Natl Acad Sci U S A; 1982 Sep; 79(18):5567-71. PubMed ID: 6291052 [TBL] [Abstract][Full Text] [Related]
17. Persistence of the mitogenic response to platelet-derived growth factor (competence) does not reflect a long-term interaction between the growth factor and the target cell. Singh JP; Chaikin MA; Pledger WJ; Scher CD; Stiles CD J Cell Biol; 1983 May; 96(5):1497-502. PubMed ID: 6841457 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of platelet-derived growth factor-mediated signal transduction and tumor growth by N-[4-(trifluoromethyl)-phenyl]5-methylisoxazole-4-carboxamide. Shawver LK; Schwartz DP; Mann E; Chen H; Tsai J; Chu L; Taylorson L; Longhi M; Meredith S; Germain L; Jacobs JS; Tang C; Ullrich A; Berens ME; Hersh E; McMahon G; Hirth KP; Powell TJ Clin Cancer Res; 1997 Jul; 3(7):1167-77. PubMed ID: 9815796 [TBL] [Abstract][Full Text] [Related]